ARCHIVES

AstraZeneca To Pay $335M In Illegal Pricing Penalties.

This article is from The Cancer Letter archive.

Vol. 29 No. 26 | June 27, 2003

Download PDF Visit The Full Archive

Related Articles

Selumetinib Plus Docetaxel Effective in KRAS-Mutant Disease

January 25, 2013

No Longer A Hands-Off Shareholder, Roche Seeks Full Control Of Genentech.

July 25, 2008

Palmetto Establishes Coverage For Thyroid Genomic Test

January 27, 2012

First-Line Tarceva Nearly Doubles PFS in EGFR-Activated Tumors

June 24, 2011

The Cancer Letter Wins Journalism Award

April 1, 2011

In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute

October 31, 2014